ArticleMedical oncology (Northwood, London, England)2025

Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosis.

Alina A Isakova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.